Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Published:2023-05 Issue:5 Volume:23 Page:379-384
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

MacDougall Kira^ORCID,Day Silas,Hall Spencer,Zhao Daniel^ORCID,Pandey Manu,Ibrahimi Sami,Khawandanah Mohamad,Chakrabarty Jennifer H.,Asch Adam,Nipp Ryan^ORCID,Al-Juhaishi Taha^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference18 articles.

1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001;Morton;Blood,2006

2. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma;McKelvey;Cancer,1976

3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

4. Network C. Rituxan Plus CHOP approved for Diffuse Large B-Cell lymphoma. 2022, 2022.

5. Rituximab in B-Cell hematologic malignancies: a review of 20 years of clinical experience;Salles;Adv Ther,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes and healthcare utilization between immigrant patients and Danish-born patients with hematological cancers: a Danish population-based study;European Journal of Epidemiology;2024-07-04

2. Racial disparities in the incidence and survival outcomes in diffuse large B‐cell lymphoma in adolescents and young adults;European Journal of Haematology;2024-06-18

3. Barriers to accessing cellular therapy for patients receiving care in community practices;Hematology;2023-12-08